Position in MRNA
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$206,588
-$311,613 QoQ
Shares Held
2,950
-39.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#503
of 772 holders
Holding Since
Mar 2022
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Abundance Wealth Counselors holds $2,464,923 across 7 Biotechnology names. MRNA ranks #6 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,815 | $901,564 | |
| 2 | INCY |
Incyte Corp
|
3,304 | $374,541 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,806 | $315,904 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
488 | $304,287 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
5,015 | $273,518 | |
| 6 | MRNA |
Moderna, Inc.
This page
|
2,950 | $206,588 | |
| 7 | IBRX |
ImmunityBio, Inc.
|
10,111 | $88,521 |
All Filings in MRNA
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $206,588 | 2,950 | Shares | Sole | 2026-07-23 | |
| 2024-03-31 | $518,201 | 4,863 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $400,584 | 4,028 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $411,713 | 3,986 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $544,806 | 4,484 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $700,017 | 4,558 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $799,668 | 4,452 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $541,939 | 4,583 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $642,253 | 4,496 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $669,057 | 3,884 | Shares | Sole | 2022-04-28 | |
| No filing history on record for this holder in this stock. | ||||||